
|Articles|July 1, 2003
Overview of Efalizumab Patient-reported Outcomes Trials
After treatment with the new biologic agents, patient-reported outcomes measuring quality of life were evaluated, since psoriasis has been shown to have a significantly negative impact on patients' physical, psychological, and social functioning.22 Because the condition can affect the ability to perform normal work activities and often causes absence from work, psoriasis can negatively affect a person's job and income.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Hilary Baldwin, MD, Highlights Emerging Acne and Rosacea Therapies at Elevate-Derm
2
Douglas DiRuggiero, PA-C, DMSc, Recognized at the Elevate-Derm Fall Conference
3
Education and Engagement Drive Momentum in Hair Disorders
4
Advancing Topical Stewardship and Expanding Nonsteroidal Options
5



















